| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4583953
Max Phase: Preclinical
Molecular Formula: C18H20O2
Molecular Weight: 268.36
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1cc(-c2ccc(C(=O)O)cc2)cc(C(C)(C)C)c1
Standard InChI: InChI=1S/C18H20O2/c1-12-9-15(11-16(10-12)18(2,3)4)13-5-7-14(8-6-13)17(19)20/h5-11H,1-4H3,(H,19,20)
Standard InChI Key: LZNBXNBFNXAUIN-UHFFFAOYSA-N
Associated Targets(Human)
RXRA Tclin Retinoid X receptor alpha (3637 Activities)
RXRB Tclin Retinoid X receptor beta (726 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
RXRG Tclin Retinoid X receptor gamma (646 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
RARA Tclin Retinoic acid receptor alpha (1324 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
RARB Tclin Retinoic acid receptor beta (1232 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PPARA Tclin Peroxisome proliferator-activated receptor alpha (9197 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PPARD Tchem Peroxisome proliferator-activated receptor delta (6293 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 268.36 | Molecular Weight (Monoisotopic): 268.1463 | AlogP: 4.66 | #Rotatable Bonds: 2 |
| Polar Surface Area: 37.30 | Molecular Species: ACID | HBA: 1 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.07 | CX Basic pKa: | CX LogP: 5.34 | CX LogD: 2.22 |
| Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.86 | Np Likeness Score: -0.68 |
References
| 1. Pollinger J, Schierle S, Gellrich L, Ohrndorf J, Kaiser A, Heitel P, Chaikuad A, Knapp S, Merk D.. (2019) A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences., 10 (9): [PMID:31531208] [10.1021/acsmedchemlett.9b00306] |
Source
Source(1):